Somatus is a prominent player in the Health Care industry, focusing on value-based kidney care. Since its founding in 2016, the company has been dedicated to advancing health equity by offering high-quality kidney and heart care to eligible members at no cost. Its commitment to patient welfare and innovative healthcare solutions has captured the attention of various investors.
The latest milestone for Somatus was its $325.00M Series E investment on 22 February 2022, showcasing the confidence that major investors have in the company's vision and strategy. Notable investors in this round include Blue Venture Fund, Flare Capital Partners, GIC, Longitude Capital, RA Capital Management, Optum Ventures, Wellington Management, Deerfield Management, Fidelity, and Elevance Health.
With its headquarters in the United States, Somatus continues to make significant strides in transforming the healthcare landscape through a focus on value-based care and patient-centric solutions. The company's innovative approach and substantial investments mark it as a key player to watch in the evolving healthcare sector.